basal cell carcinoma (Cancer)
Information
- Disease name
- basal cell carcinoma
- Disease ID
- DOID:2513
- Description
- "A skin carcinoma affecting basal cells." [url:http\://en.wikipedia.org/wiki/Basal-cell_carcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04066504 | Active, not recruiting | Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma | March 11, 2019 | November 1, 2025 | |
| NCT06024629 | Active, not recruiting | cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study | September 1, 2023 | September 1, 2024 | |
| NCT05202860 | Active, not recruiting | Phase 2 | Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic Keratosis | May 9, 2022 | June 2035 |
| NCT04552990 | Active, not recruiting | Phase 2 | Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma | September 9, 2020 | September 9, 2024 |
| NCT03775525 | Active, not recruiting | Phase 1 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer | March 1, 2019 | December 2023 |
| NCT03467789 | Active, not recruiting | Phase 1 | Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma | October 1, 2018 | September 1, 2024 |
| NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
| NCT06227416 | Active, not recruiting | N/A | Skin Tumor Biomarkers by Mass Spectrometry Imaging | June 15, 2020 | May 31, 2025 |
| NCT03982212 | Active, not recruiting | Phase 1 | A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors | July 26, 2019 | July 2024 |
| NCT03836105 | Active, not recruiting | CemiplimAb Survivorship Epidemiology | June 27, 2019 | October 28, 2025 | |
| NCT04928222 | Active, not recruiting | Phase 1/Phase 2 | Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | September 24, 2021 | June 30, 2024 |
| NCT01160250 | Approved for marketing | A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | July 2010 | April 2012 | |
| NCT00540566 | Completed | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | June 1999 | July 2008 | |
| NCT00574392 | Completed | Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo | November 2006 | September 2013 | |
| NCT00578214 | Completed | N/A | Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery | March 2007 | June 2008 |
| NCT00581425 | Completed | Phase 4 | Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC) | December 2007 | September 2011 |
| NCT00586040 | Completed | Phase 2 | Photochemical Tissue Bonding | September 2007 | April 2009 |
| NCT00601185 | Completed | Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. | February 14, 2006 | February 23, 2018 | |
| NCT00765193 | Completed | N/A | The Impact of Total Body Skin Examination on Skin Cancer Detection | May 2008 | May 2009 |
| NCT00793169 | Completed | Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery | September 2007 | July 2008 | |
| NCT00833417 | Completed | Phase 2 | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma | February 2009 | April 2014 |
| NCT00836342 | Completed | Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer | February 2009 | January 2012 | |
| NCT00880308 | Completed | Phase 1 | Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors | March 2009 | July 2013 |
| NCT00882791 | Completed | Basal Cell Carcinoma Recurrence After Mohs Surgery | May 2008 | May 2009 | |
| NCT00959647 | Completed | Phase 2 | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study | September 2009 | January 2014 |
| NCT00985829 | Completed | Phase 1 | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma | January 2008 | March 2009 |
| NCT00988455 | Completed | Phase 1/Phase 2 | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up | January 2008 | August 2009 |
| NCT01014819 | Completed | A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions | October 2009 | July 2011 | |
| NCT01015898 | Completed | Phase 1 | Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma | January 2008 | September 2008 |
| NCT01016899 | Completed | Electronic Brachytherapy for the Treatment of NMSC | August 2009 | August 2013 | |
| NCT01201915 | Completed | Phase 2 | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma | October 2010 | May 2013 |
| NCT01208831 | Completed | Phase 1 | An East Asian Study of LDE225 | October 2010 | October 2013 |
| NCT01212549 | Completed | Phase 3 | Comparison of Two Schemes of Cryosurgery and Imiquimod Combination Treatment for Basal Cell Carcinoma | February 2009 | January 2010 |
| NCT01212562 | Completed | Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery | April 2007 | August 2011 | |
| NCT01245972 | Completed | N/A | Pilot Study of PDL to Treat BCC and SCCIS | August 2010 | June 2011 |
| NCT01260987 | Completed | Phase 2/Phase 3 | Fractional CO2 Laser Assisted Photodynamic Therapy | October 2010 | August 2012 |
| NCT01298167 | Completed | N/A | Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery | February 2011 | August 2012 |
| NCT01327053 | Completed | Phase 2 | A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | June 29, 2011 | June 29, 2018 |
| NCT01350115 | Completed | Phase 2 | Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | April 2011 | October 2012 |
| NCT01358045 | Completed | Phase 2 | Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma | November 2011 | May 2013 |
| NCT01367665 | Completed | Phase 2 | STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | July 1, 2011 | June 14, 2017 |
| NCT01370824 | Completed | Clinical Diagnosis of Basal Cell Carcinoma Subtype | June 2011 | February 2013 | |
| NCT01403480 | Completed | Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions | January 2008 | February 2011 | |
| NCT01498250 | Completed | Microarray Analysis of microRNA Expression in Basal Cell Carcinoma | November 2011 | December 2011 | |
| NCT01529450 | Completed | N/A | Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors | February 2012 | August 2013 |
| NCT01540695 | Completed | Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology | February 2012 | January 2013 | |
| NCT01543581 | Completed | Phase 2 | Vismodegib for Treatment of Basal Cell Carcinoma | May 2012 | July 2013 |
| NCT01609179 | Completed | N/A | IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 | March 2012 | November 2012 |
| NCT01700049 | Completed | Phase 2 | Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes | January 14, 2013 | July 3, 2018 |
| NCT01770002 | Completed | N/A | Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? | January 2012 | September 2014 |
| NCT01773447 | Completed | N/A | Set-back Suture Versus Traditional Vertical Mattress Suture | August 2011 | April 2014 |
| NCT01815840 | Completed | Phase 2 | A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas | April 30, 2013 | August 31, 2016 |
| NCT01872130 | Completed | Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins | May 2013 | April 28, 2020 | |
| NCT02100111 | Completed | An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants | January 1, 2005 | December 31, 2011 | |
| NCT02120677 | Completed | Early Phase 1 | Topical Itraconazole in the Treatment of Basal Cell Carcinoma | May 2014 | January 30, 2019 |
| NCT02125669 | Completed | N/A | Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas | November 2012 | September 2013 |
| NCT02158650 | Completed | N/A | Video-Based Treatment Options for Basal Cell Carcinoma | July 2014 | August 2015 |
| NCT02296970 | Completed | An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence | December 2014 | December 31, 2018 | |
| NCT00005660 | Completed | The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases | October 1977 | November 2001 | |
| NCT00046189 | Completed | Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum | April 7, 2003 | January 5, 2024 | |
| NCT00108121 | Completed | Phase 2 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma | March 2005 | May 2006 |
| NCT00108134 | Completed | Phase 2 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | March 2005 | March 2006 |
| NCT00129519 | Completed | Phase 3 | A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence | January 2004 | January 2006 |
| NCT00189241 | Completed | Phase 3 | A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma | February 2001 | February 2007 |
| NCT00314756 | Completed | Phase 4 | Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage | March 2005 | November 2005 |
| NCT00374062 | Completed | N/A | Effect of the Subconscious on Mohs Micrographic Surgery | December 2007 | August 2009 |
| NCT00472043 | Completed | Phase 3 | PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma | October 2000 | September 2002 |
| NCT00472108 | Completed | Phase 3 | Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma | December 2000 | April 2002 |
| NCT00472459 | Completed | Phase 3 | PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer | July 2003 | July 2006 |
| NCT00473343 | Completed | Phase 3 | Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma | September 2000 | June 2006 |
| NCT02371967 | Completed | A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC) | April 8, 2015 | August 19, 2020 | |
| NCT02409628 | Completed | N/A | EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds | April 23, 2015 | July 2017 |
| NCT02438644 | Completed | Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina | June 30, 2015 | July 26, 2017 | |
| NCT02580916 | Completed | N/A | Utility of the Skin Cancer Quality of Life Impact Tool | July 2015 | November 2017 |
| NCT02639117 | Completed | Phase 1 | Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas | November 30, 2015 | November 18, 2017 |
| NCT02662244 | Completed | N/A | Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma | September 2015 | September 2016 |
| NCT02667574 | Completed | Phase 2 | Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) | November 18, 2014 | July 15, 2020 |
| NCT02781389 | Completed | Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions | April 29, 2016 | May 31, 2021 | |
| NCT02825511 | Completed | Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma | March 16, 2015 | September 6, 2019 | |
| NCT02902822 | Completed | N/A | Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo | October 2016 | May 2019 |
| NCT03035188 | Completed | Phase 2 | Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma | January 2017 | January 2021 |
| NCT03167762 | Completed | N/A | Photographing the Skin During Photodynamic Therapy | June 22, 2017 | June 1, 2021 |
| NCT03237013 | Completed | N/A | Strategies to Promote Skin Health | February 18, 2016 | January 14, 2017 |
| NCT03331874 | Completed | RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma | March 3, 2017 | December 31, 2019 | |
| NCT03458117 | Completed | Phase 1 | T-VEC in Non-melanoma Skin Cancer | April 19, 2018 | March 15, 2022 |
| NCT03509415 | Completed | Reflectance Confocal Microscopy to Diagnose BCC | March 15, 2017 | December 28, 2019 | |
| NCT03509467 | Completed | N/A | Using MC1R Genotype to Impact Melanoma Risk Behavior | August 3, 2015 | February 19, 2021 |
| NCT03517488 | Completed | Phase 1 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | July 10, 2018 | September 6, 2022 |
| NCT03610620 | Completed | N/A | Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery | June 12, 2017 | August 9, 2018 |
| NCT03714529 | Completed | Phase 2 | A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma | November 1, 2018 | February 5, 2020 |
| NCT04279535 | Completed | Early Phase 1 | Topical Vitamin C for Treatment of Basal Cell Cancer | March 1, 2018 | June 1, 2019 |
| NCT04416516 | Completed | Phase 2 | Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor | July 16, 2020 | February 14, 2024 |
| NCT04669808 | Completed | Phase 2 | Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma | December 28, 2020 | February 9, 2023 |
| NCT04795297 | Completed | Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation | February 1, 2020 | February 20, 2021 | |
| NCT04925713 | Completed | Phase 1 | IFx-Hu2.0 for the Treatment of Patients With Skin Cancer | June 10, 2021 | March 10, 2022 |
| NCT04936932 | Completed | N/A | Laser Treatment of Basal Cell Carcinoma | November 1, 2021 | August 20, 2022 |
| NCT04969419 | Completed | Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo | June 18, 2021 | April 4, 2023 | |
| NCT05077033 | Completed | Phase 1 | Intratumoral phIL12 GET | September 28, 2021 | November 30, 2023 |
| NCT05126173 | Completed | DERM US and EU Validation Study | March 15, 2022 | September 15, 2022 | |
| NCT05581342 | Completed | N/A | Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment | January 15, 2021 | March 4, 2022 |
| NCT05608902 | Completed | Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA) | September 6, 2022 | March 31, 2023 | |
| NCT05634421 | Completed | Training Health Care Professional in Detecting BCC on OCT Using E-learning and CUSUM-analysis | December 1, 2022 | December 31, 2023 | |
| NCT05853315 | Completed | BCC Excision Revisited | November 12, 2019 | May 1, 2023 | |
| NCT06046144 | Completed | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors | November 2, 2022 | May 1, 2023 | |
| NCT05898347 | Enrolling by invitation | Nevoid Basal Cell Carcinomas in Gorlin Syndrome | June 1, 2023 | December 31, 2025 | |
| NCT04814953 | Enrolling by invitation | HRQoL Keratinocyte Carcinomas | July 1, 2020 | December 31, 2025 | |
| NCT00535080 | No longer available | Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease | |||
| NCT06398418 | Not yet recruiting | Phase 1 | R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors | June 1, 2024 | September 30, 2026 |
| NCT06384924 | Not yet recruiting | Raman Spectroscopy and Skin Cancer | May 16, 2024 | April 30, 2025 | |
| NCT05212246 | Not yet recruiting | Phase 3 | Basal Cell Carcinoma Chemoprevention Trial | January 15, 2025 | January 15, 2031 |
| NCT06273709 | Not yet recruiting | Remote Assessment of OCT Scans for BCC Detection | March 1, 2024 | December 31, 2024 | |
| NCT05561634 | Not yet recruiting | Phase 2 | Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma | July 2023 | July 2028 |
| NCT06273722 | Not yet recruiting | D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study | April 1, 2024 | December 31, 2024 | |
| NCT06384053 | Not yet recruiting | N/A | Skin Cancer and Hyperthermia and Radiotherapy | July 1, 2024 | July 1, 2028 |
| NCT06448936 | Not yet recruiting | Quality of Life in Patients With Difficult-to-treat Basal Cell Carcinoma | June 3, 2024 | September 30, 2025 | |
| NCT04480645 | Not yet recruiting | Early Phase 1 | CivaDerm(TM) Surface Therapy Pilot Study | October 1, 2022 | April 30, 2023 |
| NCT03889912 | Recruiting | Phase 1 | Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma | April 11, 2019 | October 22, 2027 |
| NCT04679480 | Recruiting | Phase 2 | Anti-PD1-antibody and Pulsed HHI for Advanced BCC | February 18, 2021 | December 30, 2024 |
| NCT03534947 | Recruiting | Phase 2 | A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma | July 23, 2019 | June 2024 |
| NCT05724875 | Recruiting | N/A | FLASH Radiotherapy for Skin Cancer | June 22, 2023 | September 2026 |
| NCT04744935 | Recruiting | N/A | Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma | January 13, 2021 | December 31, 2025 |
| NCT05698706 | Recruiting | N/A | High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma | December 14, 2022 | May 14, 2025 |
| NCT06252857 | Recruiting | Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma | April 22, 2024 | April 2026 | |
| NCT05648604 | Recruiting | N/A | Mentored Community Gardening for Individuals With Skin Cancer | February 2, 2023 | December 30, 2024 |
| NCT06309836 | Recruiting | Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma | June 23, 2021 | June 23, 2024 | |
| NCT05020912 | Recruiting | Phase 2 | Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy | December 13, 2021 | December 2027 |
| NCT06342297 | Recruiting | N/A | Dermatoscopy Guided Resection for Skin Cancer | January 14, 2024 | January 14, 2026 |
| NCT05086692 | Recruiting | Phase 1/Phase 2 | A Beta-only IL-2 ImmunoTherapY Study | August 27, 2021 | December 30, 2026 |
| NCT05110924 | Recruiting | N/A | RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly | November 1, 2021 | October 31, 2026 |
| NCT06344052 | Recruiting | Phase 2 | To Assess the Safety and Efficacy of SP-002 With Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma | April 9, 2024 | March 30, 2029 |
| NCT05170035 | Recruiting | N/A | Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery | February 1, 2022 | February 2024 |
| NCT05188729 | Recruiting | Phase 2 | Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma | February 1, 2022 | June 30, 2024 |
| NCT05247710 | Recruiting | Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis | December 9, 2022 | June 2024 | |
| NCT05473507 | Recruiting | A Study of Observation and Follow-up in People With Basal Cell Carcinoma | July 27, 2022 | July 2025 | |
| NCT05463757 | Recruiting | Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study | November 1, 2021 | December 2024 | |
| NCT03521830 | Recruiting | Phase 2 | Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma | November 27, 2018 | March 2027 |
| NCT05859074 | Recruiting | Phase 1 | A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer | May 4, 2023 | May 4, 2028 |
| NCT06422936 | Recruiting | Phase 2 | Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) | May 27, 2024 | June 2028 |
| NCT05817279 | Recruiting | AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma | April 10, 2023 | December 31, 2024 | |
| NCT04349436 | Recruiting | Phase 1/Phase 2 | A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies | May 15, 2020 | January 2028 |
| NCT06014619 | Recruiting | Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs | August 1, 2023 | June 2024 | |
| NCT06150144 | Recruiting | Phase 3 | The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma | May 25, 2023 | May 25, 2025 |
| NCT05814900 | Recruiting | N/A | Investigation of Mohs Surgical Margins Using Two Photon Microscopy | June 20, 2023 | July 1, 2025 |
| NCT05741073 | Recruiting | Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC | June 30, 2023 | December 2027 | |
| NCT05294120 | Recruiting | Phase 2 | A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma | March 3, 2022 | March 2025 |
| NCT05234658 | Recruiting | Phase 2 | Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery | January 21, 2022 | December 1, 2024 |
| NCT04916002 | Suspended | Phase 2 | A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer | November 30, 2021 | July 29, 2027 |
| NCT04688749 | Terminated | Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage | July 17, 2019 | December 31, 2022 | |
| NCT04410874 | Terminated | Phase 1/Phase 2 | Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer | November 16, 2020 | May 23, 2023 |
| NCT00049959 | Terminated | Phase 3 | Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. | March 2004 | |
| NCT01604252 | Terminated | An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC) | June 20, 2012 | April 28, 2017 | |
| NCT02059252 | Terminated | Phase 1/Phase 2 | Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold | August 2014 | March 2016 |
| NCT03646188 | Terminated | Phase 1 | Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) | June 10, 2020 | May 4, 2021 |
| NCT01898598 | Terminated | Phase 2 | A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma | January 23, 2014 | January 26, 2016 |
| NCT02576769 | Unknown status | The Role of Melanocyte in Basal Cell Carcinoma | November 2015 | December 2016 | |
| NCT02352428 | Unknown status | N/A | Skin Cancer Screening Education Study | February 2015 | September 2019 |
| NCT03742726 | Unknown status | N/A | Study Assessing the Safety and Performance of Smart Matrix® | October 12, 2018 | January 2022 |
| NCT00449358 | Unknown status | N/A | Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors | February 2006 | April 2013 |
| NCT05340543 | Unknown status | Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV) | December 16, 2021 | June 16, 2022 | |
| NCT05402046 | Unknown status | N/A | Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms | April 23, 2022 | April 2024 |
| NCT05324202 | Unknown status | N/A | New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management | September 1, 2022 | April 2023 |
| NCT00463359 | Unknown status | N/A | A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base | ||
| NCT05046262 | Unknown status | Phase 3 | Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study | January 8, 2020 | February 22, 2022 |
| NCT05041777 | Unknown status | Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma | February 15, 2017 | December 30, 2021 | |
| NCT03734913 | Unknown status | Phase 1 | A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors | January 25, 2019 | July 31, 2021 |
| NCT04929535 | Unknown status | Phase 2 | Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment | September 2022 | December 2023 |
| NCT04759261 | Unknown status | N/A | SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity | December 1, 2020 | December 31, 2022 |
| NCT03092830 | Unknown status | Molecular Characterization of Cutaneous Tumors | March 29, 2017 | August 7, 2020 | |
| NCT04695015 | Unknown status | Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm | December 31, 2020 | June 1, 2022 | |
| NCT00663650 | Unknown status | Phase 3 | Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control | August 2008 | June 2013 |
| NCT03370861 | Unknown status | How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes | November 8, 2017 | December 31, 2022 | |
| NCT04229277 | Unknown status | N/A | Fast Track Diagnosis of Skin Cancer by Advanced Imaging | September 9, 2019 | June 1, 2021 |
| NCT01903239 | Unknown status | N/A | Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas | November 2011 | January 2017 |
| NCT01265472 | Unknown status | Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy | January 2011 | July 2011 | |
| NCT01603810 | Unknown status | Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma | |||
| NCT03972748 | Unknown status | N/A | Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin. | January 5, 2018 | June 1, 2021 |
| NCT03848078 | Unknown status | N/A | (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) | February 26, 2019 | October 2021 |
| NCT02321982 | Withdrawn | N/A | Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery | February 2015 | June 29, 2017 |
| NCT04093401 | Withdrawn | N/A | The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated. | June 2021 | November 2021 |
| NCT04099446 | Withdrawn | A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer | October 2019 | December 2020 | |
| NCT03070691 | Withdrawn | Phase 2/Phase 3 | Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | ||
| NCT04510727 | Withdrawn | N/A | Optical Coherence Tomography Guided C&D | April 1, 2024 | February 1, 2025 |
- Exact Synonym (Disease Ontology)
- Basal cell cancer
- Exact Synonym (Disease Ontology)
- Basal cell carcinoma of skin
- Exact Synonym (Disease Ontology)
- Basal cell neoplasm
- Exact Synonym (Disease Ontology)
- Basal cell tumor
- Exact Synonym (Disease Ontology)
- Epithelioma basal cell
- Exact Synonym (Disease Ontology)
- malignant Basal cell neoplasm
- Exact Synonym (Disease Ontology)
- malignant basal cell tumor
- Exact Synonym (Disease Ontology)
- Rodent ulcer
- Disase is a (Disease Ontology)
- DOID:3451
- Cross Reference ID (Disease Ontology)
- EFO:0004193
- Cross Reference ID (Disease Ontology)
- ICDO:8090/3
- Cross Reference ID (Disease Ontology)
- KEGG:05217
- Cross Reference ID (Disease Ontology)
- MESH:D018295
- Cross Reference ID (Disease Ontology)
- NCI:C156767
- Cross Reference ID (Disease Ontology)
- NCI:C3784
- Cross Reference ID (Disease Ontology)
- NCI:C7586
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:127570002
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154507009
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:252995000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0007117
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0206710
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1368295
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002671